These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 33599431)

  • 21. Non-specific effect of omega-3 fatty acid supplementation on autistic spectrum disorder: systematic review and meta-analysis.
    de Andrade Wobido K; de Sá Barreto da Cunha M; Miranda SS; da Mota Santana J; da Silva DCG; Pereira M
    Nutr Neurosci; 2022 Sep; 25(9):1995-2007. PubMed ID: 33871323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin D status in autism spectrum disorders and the efficacy of vitamin D supplementation in autistic children.
    Saad K; Abdel-Rahman AA; Elserogy YM; Al-Atram AA; Cannell JJ; Bjørklund G; Abdel-Reheim MK; Othman HA; El-Houfey AA; Abd El-Aziz NH; Abd El-Baseer KA; Ahmed AE; Ali AM
    Nutr Neurosci; 2016 Oct; 19(8):346-351. PubMed ID: 25876214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Correlation between serum 25-hydroxyvitamin D level and core symptoms of autism spectrum disorder in children].
    Dong HY; Wang B; Li HH; Shan L; Jia FY
    Zhonghua Er Ke Za Zhi; 2017 Dec; 55(12):916-919. PubMed ID: 29262471
    [No Abstract]   [Full Text] [Related]  

  • 24. Omega-3 fatty acid supplementation for cystic fibrosis.
    Watson H; Stackhouse C
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD002201. PubMed ID: 32275788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. l-Carnosine As an Adjunctive Therapy to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Hajizadeh-Zaker R; Ghajar A; Mesgarpour B; Afarideh M; Mohammadi MR; Akhondzadeh S
    J Child Adolesc Psychopharmacol; 2018 Feb; 28(1):74-81. PubMed ID: 29027815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized, placebo controlled trial of omega-3 fatty acids in the treatment of young children with autism.
    Mankad D; Dupuis A; Smile S; Roberts W; Brian J; Lui T; Genore L; Zaghloul D; Iaboni A; Marcon PM; Anagnostou E
    Mol Autism; 2015; 6():18. PubMed ID: 25798215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of prefrontal transcranial direct current stimulation (tDCS) on theory of mind, emotion regulation and emotional-behavioral functions in children with autism disorder: A randomized, sham-controlled, and parallel-group study.
    Zemestani M; Hoseinpanahi O; Salehinejad MA; Nitsche MA
    Autism Res; 2022 Oct; 15(10):1985-2003. PubMed ID: 36069668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Internet-based, randomized, controlled trial of omega-3 fatty acids for hyperactivity in autism.
    Bent S; Hendren RL; Zandi T; Law K; Choi JE; Widjaja F; Kalb L; Nestle J; Law P
    J Am Acad Child Adolesc Psychiatry; 2014 Jun; 53(6):658-66. PubMed ID: 24839884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between Long Chain n-3 Polyunsaturated Fatty Acids and Autism Spectrum Disorder: Systematic Review and Meta-Analysis of Case-Control and Randomised Controlled Trials.
    Mazahery H; Stonehouse W; Delshad M; Kruger MC; Conlon CA; Beck KL; von Hurst PR
    Nutrients; 2017 Feb; 9(2):. PubMed ID: 28218722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrathecal autologous bone marrow stem cell therapy in children with autism: A randomized controlled trial.
    Sharifzadeh N; Ghasemi A; Tavakol Afshari J; Moharari F; Soltanifar A; Talaei A; Pouryousof HR; Nahidi M; Fayyazi Bordbar MR; Ziaee M
    Asia Pac Psychiatry; 2021 Jun; 13(2):e12445. PubMed ID: 33150703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-Chain Omega-3 Fatty Acid Supplements in Depressed Heart Failure Patients: Results of the OCEAN Trial.
    Jiang W; Whellan DJ; Adams KF; Babyak MA; Boyle SH; Wilson JL; Patel CB; Rogers JG; Harris WS; O'Connor CM
    JACC Heart Fail; 2018 Oct; 6(10):833-843. PubMed ID: 30098961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of vitamin D supplementation on core symptoms, serum serotonin, and interleukin-6 in children with autism spectrum disorders: A randomized clinical trial.
    Javadfar Z; Abdollahzad H; Moludi J; Rezaeian S; Amirian H; Foroughi AA; Nachvak SM; Goharmehr N; Mostafai R
    Nutrition; 2020; 79-80():110986. PubMed ID: 32966919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of ω-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders: The NEURAPRO Randomized Clinical Trial.
    McGorry PD; Nelson B; Markulev C; Yuen HP; Schäfer MR; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EY; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Thompson A; Yung AR; Amminger GP
    JAMA Psychiatry; 2017 Jan; 74(1):19-27. PubMed ID: 27893018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Omega-3 PUFAs and vitamin D co-supplementation as a safe-effective therapeutic approach for core symptoms of autism spectrum disorder: case report and literature review.
    Infante M; Sears B; Rizzo AM; Mariani Cerati D; Caprio M; Ricordi C; Fabbri A
    Nutr Neurosci; 2020 Oct; 23(10):779-790. PubMed ID: 30545280
    [No Abstract]   [Full Text] [Related]  

  • 35. Fat intake in children with autism spectrum disorder in the Mediterranean region (Valencia, Spain).
    Marí-Bauset S; Llopis-González A; Zazpe I; Marí-Sanchis A; Suárez-Varela MM
    Nutr Neurosci; 2016 Nov; 19(9):377-386. PubMed ID: 26020227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of multiple-dose intranasal oxytocin administration on social responsiveness in children with autism: a randomized, placebo-controlled trial.
    Daniels N; Moerkerke M; Steyaert J; Bamps A; Debbaut E; Prinsen J; Tang T; Van der Donck S; Boets B; Alaerts K
    Mol Autism; 2023 Apr; 14(1):16. PubMed ID: 37081454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can ω-3 fatty acids and tocotrienol-rich vitamin E reduce symptoms of neurodevelopmental disorders?
    Gumpricht E; Rockway S
    Nutrition; 2014; 30(7-8):733-8. PubMed ID: 24631384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased ω-3 polyunsaturated fatty acid/arachidonic acid ratios and upregulation of signaling mediator in individuals with autism spectrum disorders.
    Yui K; Imataka G; Kawasak Y; Yamada H
    Life Sci; 2016 Jan; 145():205-12. PubMed ID: 26724495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complementary and Alternative Medicine in Autism: The Question of Omega-3.
    Posar A; Visconti P
    Pediatr Ann; 2016 Mar; 45(3):e103-7. PubMed ID: 27031309
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.